-
-
Any risk manager with hopes of reducing birth trauma rates should look to The Seton Family of Hospitals, based in Austin, TX, for lessons in what can yield dramatic results.
-
Four recognized categories of hospital-acquired conditions, "never events" that have received more attention in recent years, make up 12.2% of total medical professional liability costs, according to the 2008 Hospital Professional Liability and Physician Liability Benchmark Analysis released recently by risk management services provider Aon Corp. and the American Society for Healthcare Risk Management (ASHRM), both in Chicago.
-
News: A woman presented to the hospital complaining of left shoulder pain, chest pain, vomiting, and nausea. She was diagnosed with pneumonia and treated with IV antibiotics for two weeks, after which she was discharged.
-
On July 15, 2008, the Department of Health and Human Services (HHS) entered into an agreement with Seattle-based Providence Health & Services to settle potential violations of HIPAA privacy rules.
-
The Department of Health and Human Services (HHS) has issued new guidance for providers on talking about patients' health information with and in the presence of other parties with an emphasis on what can be discussed.
-
This study showed that intra-abdominal hypertension is associated with increased organ dysfunction and higher ICU mortality, and two commonly used methods for measuring intra-abdominal pressure have equivalent predictive capabilities.
-
In a prospective study of immunocompetent patients admitted to critical care units, CMV viremia showed a significant association with prolonged ICU stay and death.
-
Perhaps the most prominent cardiovascular report in 2007 was the publication of the COURAGE trial (N Engl J Med. 2007;356:1503-1516), which demonstrated the equality in major CV outcomes in randomized patients with stable CAD, most with angina, who were assigned PCI with optimal medical therapy (OMT) vs OMT alone, with a mean follow-up of 4.6 years.
-
A randomized, controlled trial in the Netherlands showed that oral prednisolone and naproxen were equivalent in the treatment of acute gout with no difference in side effects.
